Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · June 04, 2023

Impact of the Publication of Protocol T Study Results on Intravitreal Anti-VEGF Usage by Ophthalmologists in the US

Current Opinion in Ophthalmology


Additional Info

Current Opinion in Ophthalmology
Do published trial results influence physician prescribing patterns? Intravitreal antivascular endothelial growth factor usage by the United States Ophthalmologists before and after Protocol T study
Curr Opin Ophthalmol 2023 May 01;34(3)218-225, S Shah, Z Markatia, A Watane, A Feldman, L Shah, J Sridhar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading